HANGZHOU, China and SHANGHAI and BOSTON, Nov. 19, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical-stage innovative drug development ...
Nektar Therapeutics has two Phase IIb studies underway for rezpeg in atopic dermatitis and severe alopecia areata, with read-outs expected in 1H'25. Success in either indication would significantly ...
GRI Bio, Inc. has announced expected interim and topline data readouts from its Phase 2a biomarker study for the lead program GRI-0621, aimed at treating idiopathic pulmonary fibrosis (IPF), in Q2 and ...
Cryptopolitan on MSN
Next altcoin to watch after BTC stalls, this new crypto under $0.1 enters a key phase
Crypto markets often pause before capital shifts direction. When Bitcoin slows near key levels, attention usually sta ...
Cytokinetics' share price surged on rumors of potential takeover interest from Novartis and AstraZeneca. The buyout of Myokardia shows how attractive an asset like aficamten can be, but the price tag ...
Pfizer’s sickle cell disease (SCD) drug has flunked a key phase 3 test, the latest blow to the pharma’s $5.4 billion acquisition of Global Blood Therapeutics. Pfizer acquired the P-selectin inhibitor, ...
PERTH AMBOY — The second phase of a massive three-phase project to rebuild NJ Transit's Raritan River Bridge began on a sweltering Tuesday, June 24. "So many of the coastal towns, of which I live in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback